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Breast-Lesion Characterization 
using Textural Features of 
Quantitative Ultrasound 
Parametric Maps
Ali Sadeghi-Naini  1,2,3,4, Harini Suraweera2,3, William Tyler Tran3,5, Farnoosh Hadizad2,3, 
Giancarlo Bruni6, Rashin Fallah Rastegar6, Belinda Curpen6 & Gregory J. Czarnota1,2,3,4
This study evaluated, for the first time, the efficacy of quantitative ultrasound (QUS) spectral 
parametric maps in conjunction with texture-analysis techniques to differentiate non-invasively benign 
versus malignant breast lesions. Ultrasound B-mode images and radiofrequency data were acquired 
from 78 patients with suspicious breast lesions. QUS spectral-analysis techniques were performed on 
radiofrequency data to generate parametric maps of mid-band fit, spectral slope, spectral intercept, 
spacing among scatterers, average scatterer diameter, and average acoustic concentration. Texture-
analysis techniques were applied to determine imaging biomarkers consisting of mean, contrast, 
correlation, energy and homogeneity features of parametric maps. These biomarkers were utilized 
to classify benign versus malignant lesions with leave-one-patient-out cross-validation. Results were 
compared to histopathology findings from biopsy specimens and radiology reports on MR images to 
evaluate the accuracy of technique. Among the biomarkers investigated, one mean-value parameter 
and 14 textural features demonstrated statistically significant differences (p < 0.05) between the two 
lesion types. A hybrid biomarker developed using a stepwise feature selection method could classify the 
legions with a sensitivity of 96%, a specificity of 84%, and an AUC of 0.97. Findings from this study pave 
the way towards adapting novel QUS-based frameworks for breast cancer screening and rapid diagnosis 
in clinic.
Breast cancer still remains the most commonly diagnosed cancer type in women accounting for 27% of all inci-
dent cases annually1. One in eight women will develop breast cancer during her lifetime and one in 30 women 
will die from it1. Rapid and accurate diagnosis and characterization of breast cancer plays a vital role in treat-
ment planning and improved prognosis. The current screening workflow for breast-cancer diagnosis begins 
with x-ray mammography, followed by standard ultrasound imaging (B-mode), dynamic contrast-enhanced 
magnetic-resonance imaging (DCE-MRI), and core-needle biopsy, as needed. Statistical reports indicate that 
patients with dense breasts have a high chance of receiving a false negative result for lesion detection based 
on mammography2. Biopsy remains the gold standard approach for pathological confirmation of malignancy 
and tumour grade characterization3. However, biopsies are invasive, painful and also carry a risk of tumour cell 
migration. Furthermore, many biopsies are also conducted unnecessarily due to “over-diagnosis’ as a result of the 
low specificity of ultrasound B-mode images4. DCE-MRI may improve the specificity of breast cancer diagnosis; 
however MRI is expensive and is often not available for rapid diagnosis due to the longer wait time associated 
with it compared to mammography and ultrasound. Development of inexpensive and potentially widely-available 
imaging techniques that can rapidly characterize breast masses with a high sensitivity and specificity is highly 
beneficial for the early diagnosis of breast cancer and triaging patients in screening workflows.
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One limitation associated with standard ultrasound imaging for breast cancer screening is that ultrasound 
B-mode images are mainly qualitative and fail to provide reliable quantitative information about underlying tissue 
microstructure5. Quantitative ultrasound (QUS) techniques have been introduced to address such limitation6. 
Such techniques analyze ultrasound radiofrequency (RF) raw data, before it is envelope detected, log ampli-
fied, and processed to form B-mode ultrasound images. These methods extract quantitative measures describ-
ing intrinsic acoustic characteristics of tissue related to underlying micro-structures7,8. Effects of operator and 
instrument-setting variables are often minimized in such methods by normalizing ultrasound signals against a 
reference in a frequency-dependent manner9,10. A number of QUS spectral parameters including mid-band fit 
(MBF), spectral slope (SS) and spectral intercept (SI) are derived by linear regression analysis on the normalized 
power spectrum of ultrasound RF data10,11. These are the parameters that can be linked to scattering power and 
the size and concentration of acoustic scatterers12,13. Two other parameters, effective scatterer diameter (ESD) and 
effective acoustic concentration (EAC), are derived by fitting a form-factor model to the backscatter coefficient 
(BSC) that can be estimated using the normalized power spectrum14. The EAC parameter is defined as the prod-
uct of the average number of scatterers per unit volume and the relative acoustic-impedance difference between 
the scatterers with the surrounding tissue15,16. Another QUS parameter, the spacing among scatterers (SAS), rep-
resents the distance between the coherent periodically-arranged scatters within tissue, and can be estimated by 
computing the autocorrelation of the normalized power spectrum estimated by an autoregressive (AR) model17.
Techniques using QUS have been demonstrated to be capable of detecting tumour response to treatment in 
preclinical models10,18 and in clinical settings11,16,19–22, differentiating between various tissue types in prostate, 
liver, and retina23–29, determining blood-clot and intravascular-plaque compositions30–32, and detecting the pres-
ence of tumour deposits in lymph nodes ex vivo33. A study on preclinical animal tumour models demonstrated 
that QUS techniques have the ability to differentiate between normal and cancerous thyroid tissues. In particular, 
parameters quantifying the size and concentration of acoustic scatterers could be used to classify normal thyroid 
tissue and C-cell adenoma (benign) versus papillary thyroid carcinoma (PTC) and follicular variant papillary 
thyroid carcinoma (FV-PTC)34. With regards to the breast cancer, previous preclinical studies have demon-
strated that QUS parameters are able to differentiate between spontaneously occurring mammary fibroadenomas 
(benign) and mammary carcinomas (malignant), and also differentiate between two types of mammary cancers: 
carcinoma and sarcoma35,36. Another study demonstrated that glandular acini are the most prevalent source of 
scattering in the fibroadenomas. Therefore, QUS parametric images indicative of the size of acoustic scatterers 
could potentially provide a good distinction between benign versus malignant lesions37. QUS techniques have 
also demonstrated the capability to differentiate breast tumours from the surrounding normal tissue in locally 
advanced disease3.
Heterogeneity in tumour micro-structure, physiology and metabolism has demonstrated diagnostic and 
prognostic values in cancer characterization38–44. Spatial heterogeneity in various characteristics of tumour can 
be detected in images acquired with different modalities including MRI45,46, positron emission tomography 
(PET)47,48, computed tomography (CT)49,50, and diffuse optical spectroscopy (DOS)51. Such heterogeneity can 
be quantified using texture-analysis techniques52. Texture-analysis techniques have been applied to ultrasound 
B-mode images in order to quantify spatial heterogeneities within tumour in tissue characterization applications, 
such as discriminating between benign and malignant breast tumours53–55. The principle behind this approach is 
that benign and malignant lesions often demonstrate homogeneous and heterogeneous internal echoes, respec-
tively. Texture-analysis techniques can quantify the spatial alterations in internal echo properties of tissue based 
on the ultrasonic gray-level transitions, and hence can define differentiable characteristics in this application. 
However, conventional ultrasound B-mode images may present undesirable variations in estimates of texture 
due to variations in instruments settings, ultrasound beam diffraction, and attenuation effects. Such limitations 
can be addressed by performing texture analysis on QUS parametric images in which these artifacts have been 
compensated. In this context, a recent study has reported significant differences in textural features determined 
from QUS parametric images at pre-treatment between responding and non-responding breast cancer patients 
to neo-adjuvant chemotherapy56. Specifically, the significant parameters were measures of inhomogeneity in size 
and concentration of scatterers within tumours. Another study recently demonstrated that QUS textural param-
eters can characterize tumours in terms of histological grade15.
The study described here has investigated the efficacy of QUS spectral parametric imaging in conjunction with 
texture-analysis techniques to differentiate benign versus malignant breast lesions using data acquired from 78 
patients with suspicious breast lesions. QUS spectral analysis techniques were performed on ultrasound RF data 
to generate parametric maps of MBF, SS, SI, SAS, ESD, and EAC. Several textural features were determined from 
each parametric map in addition to an average-based mean-value parameter as imaging biomarkers. These bio-
markers were utilized to classify benign versus malignant lesions using a k-nearest neighbour (K-NN) classifier 
with leave-one-patient-out cross-validation. Results were compared to findings from biopsy specimens and mag-
netic resonance (MR) images to evaluate performance of the technique. Among the QUS parameters investigated, 
one mean-value parameter and 14 textural features demonstrated statistically significant differences between the 
benign versus malignant lesions. An accuracy of greater than 80% was achieved by eight single biomarkers used 
to classify the two lesion types. A hybrid biomarker developed using a stepwise feature selection method classi-
fied the benign and malignant breast legions with an accuracy of 91% and an area under the receiver operating 
characteristic (ROC) curve (AUC) of 0.97. The observations in this study suggest that QUS spectral parametric 
imaging along with texture-analysis methods have a high potential to characterize suspicious breast lesions rap-
idly, non-invasively, and with high sensitivity and specificity.
Material and Methods
Study Protocol and Data Acquisition. The study was conducted in accordance with institutional 
research-ethics-board approval (Sunnybrook Health Sciences Centre). After obtaining informed consent, 
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ultrasound B-mode images and radiofrequency (RF) data were acquired from 78 patients recruited in the Rapid 
Diagnostic Unit (RDU) of Louise Temerty Breast Cancer Centre at Sunnybrook Health Sciences Centre, Toronto, 
Ontario, Canada. Data acquisition was performed by an experienced sonographer using a SonixTouch system 
(Ultrasonix, Vancouver, Canada) equipped with a linear array transducer (L14-5/60 W) with a centre frequency of 
~6 MHz and sampling rate of 40 MHz. Data were acquired along 512 lateral scan lines (6 cm lateral field of view) 
with an imaging depth of 4 cm. The focus of transducer was set at the midline of the tumour. Ultrasound images 
and RF data were acquired at about 5 mm intervals over the entire tumour volume. Dynamic contrast-enhanced 
MR images and core biopsy specimens were acquired from the patients as gold standard approaches for breast-le-
sion characterization and cancer diagnosis. Clinical reports including results from MR images and biopsy speci-
mens were used as ground truth to identify benign versus malignant lesions.
Feature Extraction and Data Analysis. QUS analysis was performed over a region-of-interest (ROI) cov-
ering the whole lesion in each imaging plane. Spatial parametric images were generated for each QUS parameter 
applying a sliding window analysis technique with a 2 mm by 2 mm sliding window (containing 17 scan lines with 
102 samples in each line) and a 94% (1.88 mm) overlap between adjacent windows in axial and lateral directions. 
A Hanning apodization was applied on individual scan lines within the sliding window. The size of the sliding 
window was selected to cover enough number of ultrasound wavelengths for reliable spectral analysis while pre-
serving texture in parametric images. The overlap between adjacent windows was selected to obtain parametric 
images with isotropic pixels (0.12 mm × 0.12 mm). A total of six QUS parameters were investigated (described 
below) including MBF, SS, SI, SAS, ESD, and EAC.
The mean normalized power spectrum was computed for each window via fast Fourier transform and phan-
tom data normalization. Normalization was performed to remove the effects of system transfer functions and 
transducer beam-forming using reference data obtained with the same scan settings from a tissue-mimicking 
phantom. The reference phantom was comprised of 5–30 µm glass beads embedded in a homogenous medium of 
microscopic oil droplets that were sunk in gelatin, and had an attenuation coefficient of 0.576 dB/MHz/cm and 
a speed of sound at 1488 m/s (University of Wisconsin, Department of Medical Physics, Madison, WI, USA). 
Attenuation correction and linear regression analysis were performed on mean normalized power spectrum and 
spectral parameters including the MBF, SS, SI were derived57. A two-layer (intervening tissue and tumour) atten-
uation correction was performed using total attenuation estimation58. The attenuation coefficient estimate (ACE) 
of tumour was calculated using a spectral difference method by estimating the rate of change in the spectral power 
magnitude with depth (over the tumour region) and frequency relative to the reference phantom59. An attenu-
ation coefficient of 1 dB/MHz.cm was assumed for intervening breast tissue based on ultrasound tomography 
measurements of the breast60. Attenuation correction was performed using the point-compensation method61. 
The ESD and EAC parameters were derived by fitting a spherical Gaussian form-factor model to the BSC esti-
mated using attenuation-corrected normalized power spectrum14.
To derive the SAS parameter, the power spectrum of sample was estimated using an autoregressive (AR) 
model and the AR model parameters were estimated using Burg’s recursive algorithm62. The power spectrum was 
then normalized to that of a planar reflector. The planar reflector normalization was performed at different depths 
using pre-recorded reference RF data acquired from a Plexiglas-water interface at different depths. For each RF 
block in the sample image, a reference RF block was selected using the nearest neighbour approach. By computing 
the autocorrelation of the normalized power spectrum, the SAS parameter was determined from the frequency at 
which the peak occurred in the autocorrelation. The method used here for SAS estimation is described in detail 
in ref.3.
In addition to an average-based mean-value parameter derived, textural parameters were extracted from each 
QUS parametric map using the method of gray-level co-occurrence matrix (GLCM)52. The GLCM represents the 
spatial relationship between the neighbouring pixels within an image. The full range of gray-level intensities in 
each parametric image was linearly scaled and quantized into 16 levels. Symmetric GLCMs were calculated for 
each parametric image at five inter-pixel distances (1, 2, 3, 4 and 5 pixels) and at four directions (0°, 45°, 90° and 
135°). Four textural features including contrast, correlation, energy and homogeneity were extracted from each 
GLCM using the equations 1–4, respectively, and were subsequently averaged over all GLCMs of each parametric 
image.
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In equations 1–4, p(i, j) is the probability of having two neighbour pixels with gray-level intensities of i and 
j in the map, and Ng is the number of quantized gray-level intensities. The µ and σ are the mean and standard 
deviations for row i or column j of the GLCM matrix. The contrast parameter quantifies local gray-level variation 
of an image, the correlation parameter represents the linear dependency among neighbouring pixels, the energy 
parameter measures textural uniformity within neighbouring pixels, and the homogeneity parameter quantifies 
the incidence of pixel pairs of different intensities.
Statistical Data Analysis. Each QUS mean-value and textural parameter was calculated for all scan 
planes and subsequently averaged across the entire volume of tumour. Statistical analysis was performed using 
non-parametric Mann-Whitney U test (two-sided, 95% confidence) to assess for any statistically significant dif-
ferences between benign versus malignant lesions using the QUS biomarkers (PASW Statistics 18, SPSS Inc., 
Chicago, IL). A stepwise linear discriminant analysis (LDA) was carried out to determine the best combination of 
parameters that significantly contributes to a hybrid biomarker to separate the two lesion types linearly. A K-NN 
classification was used to evaluate the efficacy of QUS parameters to differentiate benign versus malignant lesions 
non-invasively63. Cross-validated sensitivity, specificity and accuracy were calculated, in addition to the AUC, to 
measure the performance of the classification. The leave-one-patient-out method was applied for cross-validation 
of classification.
Data Availability Statement. Data were collected and available at the Odette Cancer Centre, Sunnybrook 
Health Sciences Centre, Toronto, ON, Canada.
Results
Among the 78 patients that participated in this study, 46 and 32 patients were confirmed with benign and malig-
nant lesions, respectively, based on radiology and pathology reports. The patients had an average age of 52 ± 14 
years, and an average tumour size of 2.2 ± 1.7 cm with respect to the largest lesion dimension. Representative MR 
and ultrasound images obtained from clinically-confirmed benign and malignant masses are presented in Fig. 1. 
Ultrasound B-mode images are demonstrated along with parametric overlays of MBF, SS, SI, SAS, ESD and EAC 
features. Overall, mean-value and textural parameters determined from these parametric maps were used to form 
quantitative “fingerprints” associated with benign versus malignant lesions.
Figure 2 presents scatter plots associated with the mean-value and textural parameters derived from each of 
the QUS parametric images for the two lesion types. The MBF-derived mean, contrast, correlation, energy and 
homogeneity parameters demonstrated average values of −1.8 ± 1.1 dBr versus −1.9 ± 0.9 dBr, 3.6 ± 0.5 A.U. 
versus 1.7 ± 0.2 A.U., 0.7 ± 0.03 A.U. versus 0.9 ± 0.01 A.U., 0.6 ± 0.02 A.U. versus 0.7 ± 0.02 A.U., and 
0.05 ± 0.01 A.U. versus 0.06 ± 0.01 A.U. for benign versus malignant lesions, respectively. The mean-value and 
textural parameters determined from the SS parametric maps demonstrated average values of −2.7 ± 0.1 dB/
MHz versus −3.0 ± 0.1 dB/MHz, 4.2 ± 0.6 A.U. versus 2.2 ± 0.3 A.U., 0.7 ± 0.02 A.U. versus 0.8 ± 0.01 A.U., 
0.6 ± 0.02 A.U. versus 0.7 ± 0.02 A.U., and 0.05 ± 0.01 A.U. versus 0.05 ± 0.01 A.U. for the two lesion types, respec-
tively. The parameters obtained from the SI parametric maps showed average values of 13.2 ± 1.2 dBr versus 
14.9 ± 0.9 dBr, 4.1 ± 0.6 A.U. versus 2.2 ± 0.3 A.U., 0.7 ± 0.03 A.U. versus 0.8 ± 0.01 A.U., 0.6 ± 0.02 A.U. versus 
0.7 ± 0.01 A.U., and 0.05 ± 0.01 A.U. versus 0.05 ± 0.01 A.U. for these lesion types, respectively. The SAS mean, 
contrast, correlation, energy and homogeneity parameters demonstrated average values of 0.7 ± 0.02 mm versus 
0.8 ± 0.02 mm, 12.3 ± 1.4 A.U. versus 9.0 ± 0.8 A.U., 0.3 ± 0.02 A.U. versus 0.4 ± 0.01 A.U., 0.6 ± 0.01 A.U. versus 
0.6 ± 0.01 A.U., and 0.06 ± 0.01 A.U. versus 0.04 ± 0.01 A.U. for benign versus malignant lesions, respectively. The 
mean-value and textural parameters extracted from the ESD parametric maps demonstrated average values of 
102.6 ± 4.4 µm versus 111.1 ± 4.1 µm, 4.9 ± 0.6 A.U. versus 3.0 ± 0.4 A.U., 0.7 ± 0.02 A.U. versus 0.8 ± 0.01 A.U., 
0.61 ± 0.02 A.U. versus 0.66 ± 0.02 A.U., and 0.07 ± 0.01 A.U. versus 0.06 ± 0.01 A.U. for the two lesion types, 
respectively. The parameters obtained from the EAC parametric maps showed average values of 38.8 ± 2.9 dB/cm3 
versus 34.5 ± 2.2 dB/cm3, 6.3 ± 1.0 A.U. versus 4.1 ± 0.9 A.U., 0.6 ± 0.02 A.U. versus 0.7 ± 0.01 A.U., 0.7 ± 0.02 A.U. 
versus 0.8 ± 0.02 A.U., and 0.2 ± 0.01 A.U. versus 0.3 ± 0.02 A.U. for these lesion types, respectively. The benign 
and malignant lesions demonstrated ACE mean-values of 1.3 ± 0.2 dB/MHz.cm and 0.8 ± 0.1 dB/MHz.cm, 
respectively.
Among the mean-value parameters, only SAS demonstrated a statistically significant difference between the 
benign and malignant lesions (p = 0.016). However, several QUS textural parameters including MBF contrast 
(p = 0.008), correlation (p = 0.004) and homogeneity (p = 0.009), SS contrast (p = 0.027), correlation (p = 0.002) 
and homogeneity (p = 0.027), SI contrast (p = 0.032), correlation (p = 0.001) and homogeneity (p = 0.034), SAS 
energy (p = 0.049), ESD contrast (p = 0.035) and correlation (p = 0.002), as well as EAC homogeneity (p < 0.001) 
and energy (p < 0.001) exhibited significant differences between the two lesion types.
Table 1 summarizes result of the stepwise linear discriminant analysis performed to form a hybrid QUS bio-
marker for lesion characterization. Seven parameters (out of 30) demonstrated a significant contribution to the 
model and were incorporated based on their level of contribution with the standardized coefficients presented in 
Table 1. Specifically, EAC homogeneity, EAC energy, MBF homogeneity, SS correlation, SAS homogeneity, MBF 
and ESD energy demonstrated the highest to lowest contributions towards the model. Figure 3 demonstrates a 
scatter plot of the hybrid QUS biomarker for the benign versus malignant lesions. A very good separation was 
provided by the hybrid biomarker between the two lesion types that was found to be statistically extremely sig-
nificant (p < 0.001).
Table 2 presents results of the cross-validated classification of breast lesions using the K-NN classifier. The 
results are presented for each single QUS parameter as well as the hybrid QUS feature vector. The hybrid feature 
vector was composed of the seven QUS parameters identified earlier through the stepwise approach. An accu-
racy of over 80% was achieved by a number of single QUS parameters, including MBF energy (sensitivity = 87%, 
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specificity = 72%, AUC = 0.93), SI homogeneity (sensitivity = 83%, specificity = 81%, AUC = 0.93), SAS (sensi-
tivity = 87%, specificity = 78%, AUC = 0.95), SAS correlation (sensitivity = 87%, specificity = 78%, AUC = 0.93), 
ESD homogeneity (sensitivity = 87%, specificity = 72%, AUC = 0.90), EAC (sensitivity = 83%, specificity = 78%, 
AUC = 0.90), EAC homogeneity (sensitivity = 93%, specificity = 66%, AUC = 0.94), and EAC energy (sensitiv-
ity = 85%, specificity = 78%, AUC = 0.94). The hybrid QUS feature vector could classify the benign and malignant 
breast legions with a sensitivity, specificity, and accuracy of 96%, 84% and 91%, respectively, and an AUC of 0.97.
Figure 1. Representative MR and ultrasound B-mode images with QUS parametric overlays of MBF, SS, SI, 
SAS, ESD, EAC obtained from a benign and a malignant lesion. The color bar represents a scale encompassing 
20 dBr for MBF, 5 dBr/MHz for SS, 30 dBr for SI, 3 mm for SAS, 160 µm for ESD, and 50 dB/cm3 for EAC. The 
scale bar represents 2 cm and 5 mm in MR and ultrasound images, respectively.
www.nature.com/scientificreports/
6SCIeNTIfIC REPORTS | 7: 13638  | DOI:10.1038/s41598-017-13977-x
Figure 2. Scatter plots of the QUS mean-value and textural parameters for benign versus malignant lesions. 
Statistically significant (p < 0.5), highly significant (p < 0.01), and extremely significant (p < 0.001) differences 
are shown with *, **, and ***, respectively.
Parameter Standardized Coefficient
EAC Homogeneity −2.30
EAC Energy 2.21
MBF Homogeneity 1.42
SS Correlation 1.26
SAS Homogeneity −0.79
MBF 0.77
ESD Energy −0.73
Table 1. The parameters with significant contribution to the hybrid QUS biomarker, identified through a 
stepwise linear discriminant analysis.
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Discussion and Conclusions
This study demonstrated, for the first time, the potential of QUS spectral and textural analysis techniques for 
characterization of benign versus malignant breast lesions non-invasively. Ultrasound B-mode images and RF 
data at clinically-relevant conventional frequencies were collected from the breast lesions of 78 patients. Several 
Figure 3. Scatter plot of the hybrid QUS biomarker for benign versus malignant lesions, demonstrating a 
statistically extremely significant difference between the lesion types (p < 0.001).
Parameter
Sensitivity 
(%)
Specificity 
(%)
Accuracy 
(%) AUC
MBF 78.3 68.7 74.4 0.86
MBF Contrast 84.8 59.4 74.4 0.87
MBF Correlation 82.6 71.9 78.2 0.91
MBF Homogeneity 78.2 75.0 76.9 0.92
MBF Energy 87.0 71.9 80.8 0.93
SS 78.3 62.5 71.8 0.86
SS Contrast 80.4 53.1 69.2 0.84
SS Correlation 78.3 68.7 74.4 0.86
SS Homogeneity 82.6 56.3 71.8 0.85
SS Energy 84.8 68.8 78.2 0.90
SI 87.0 65.6 78.2 0.85
SI Contrast 80.4 75.0 78.2 0.89
SI Correlation 82.6 75.0 79.5 0.94
SI Homogeneity 82.6 81.3 82.1 0.93
SI Energy 87.0 65.6 78.2 0.94
SAS 87.0 78.1 83.3 0.95
SAS Contrast 82.6 68.8 76.9 0.89
SAS Correlation 87.0 78.1 83.3 0.93
SAS Homogeneity 80.4 71.9 76.9 0.88
SAS Energy 87.0 59.4 75.6 0.88
ESD 89.1 59.4 76.9 0.84
ESD Contrast 87.0 68.8 79.5 0.92
ESD Correlation 78.3 75.0 76.9 0.88
ESD Homogeneity 87.0 71.9 80.8 0.90
ESD Energy 89.1 65.6 79.5 0.92
EAC 82.6 78.1 80.8 0.90
EAC Contrast 87.0 59.4 75.6 0.88
EAC Correlation 82.6 71.9 78.2 0.95
EAC Homogeneity 93.5 65.6 82.1 0.94
EAC Energy 84.8 78.1 82.1 0.94
Hybrid Vector 95.7 84.4 91.0 0.97
Table 2. Cross-validated results of breast-lesion classification using different QUS biomarkers.
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QUS parametric maps were generated using spectral analysis techniques in conjunction with a sliding window 
analysis. Average-based mean-value parameters were determined from each parametric map in addition to four 
textural features to quantify intra-lesion heterogeneity in tissue micro-structures. The QUS-based biomarkers 
derived were applied to differentiate between the benign versus malignant lesions non-invasively. The ground 
truth lesion characteristics were identified from histopathology on biopsy specimens and radiology reports 
related to clinical MR images. Several QUS biomarkers (one mean-value and 14 textural parameters) demon-
strated statistically significant differences between the benign versus malignant lesions. Using a K-NN classifier 
with leave-one-patient-out cross-validation, several single biomarkers including two mean-value and six textural 
parameters could classify the lesions with a greater than 80% accuracy. A hybrid vector of biomarkers developed 
using the stepwise feature selection method achieved a sensitivity of 96%, a specificity of 84%, and an AUC of 
0.97.
Among the mean-value parameters, only SAS demonstrated a statistically significant difference between the 
two lesion types. This can be due to the fact that the average size of lesions in this study was relatively large 
(2.2 ± 1.7 cm) and QUS parametric images frequently demonstrated considerable levels of spatial heterogeneity 
within tumour area. Average-based parameters characterize a lesion by only a mean value and do not carry any 
information regarding intra-lesion heterogeneity. Due to the high level of spatial variations observed in param-
eter values within lesions, the average of parameters over the entire lesion may not represent its micro-structure 
appropriately. Therefore one can expect that mean-value parameters cannot differentiate between the two lesion 
types effectively. This is in agreement with the observations of another study that applied QUS spectral analysis 
techniques to differentiate between different grades of locally advanced breast cancer3. In that study, similarly no 
QUS mean-value parameter except SAS demonstrated any statistically significant difference between the tumour 
grades.
The QUS textural parameters determined here demonstrated better performance in differentiating between 
benign versus malignant lesions. Particularly, among the textural parameters six single biomarkers showed sta-
tistically significant differences (p < 0.05), six demonstrated statistically highly significant differences (p < 0.01), 
and two exhibited statistically extremely significant (p < 0.001) differences between the two lesion types. QUS 
textural parameters quantify intra-lesion heterogeneities in size, density and the distribution of acoustic scatter-
ers. Therefore, these parameters can potentially characterize tissue micro-structure from different perspectives 
and provide a better separation between different histological tissue types compared to mean-value parameters. 
A number of other studies have applied texture-analysis techniques with different imaging modalities including 
PET, MRI, CT and ultrasound in various diagnostic and prognostic applications38–44. In line with the observations 
in this study, those studies also reported a favorable potential of using imaging-based texture-analysis techniques 
to characterize heterogeneity in tumour micro-structure, perfusion, physiology, and cell death with diagnostic 
and prognostic values for cancer characterization.
Results of stepwise linear discriminant analysis demonstrated that a combination of mean and textural param-
eters in form of a hybrid QUS biomarker provided a better separation between the two lesion types with “extreme” 
statistical significance (p < 0.001). Such an observation implies that whereas the textural biomarkers can gener-
ally better quantify unique micro-structure of each lesion type, the QUS mean-value parameters can provide 
near-orthogonal information reflecting major difference in histological characteristics of the lesion types in order 
to form a robust hybrid biomarker. This is in agreement with findings of previous studies where a combination of 
QUS mean-value and textural parameters demonstrated a better performance in grading breast tumours as well 
as in detecting cell death-related alterations in tissue micro-structure3,22. Classification results obtained in the 
study here using a leave-one-patient-out cross-validation scheme also suggested a higher potential of QUS tex-
tural biomarkers compared to mean-value parameters for breast-lesion categorization. Similarly, a combination 
of textural and mean-value parameters resulted in a higher sensitivity and specificity for breast-lesion classifica-
tion. The number of cases in this study (n = 78) is more than 10 times greater than the number of parameters in 
the hybrid biomarker (n = 7) applied for classification. However further studies on larger cohorts of patients are 
required to ensure that the classification results are repeatable and not affected by possible excessive dimension-
ality of the feature vector.
A recent study reported good potential for tumour-core-to-margin ratio of QUS parameters to characterize 
breast tumour aggressiveness and predict its response to chemotherapy56. Benign and malignant lesions of breast 
often demonstrate different marginal characteristics64. Therefore, the QUS core-to-margin ratios may potentially 
improve the performance of the lesion characterization framework proposed in this study. Such approach has 
been planned to be investigated in a future study on larger cohort of patients.
Other imaging modalities including x-ray mammography, standard ultrasound (B-mode), and 
contrast-enhanced MRI are conventionally applied in clinic for breast cancer diagnosis. Compared to these imag-
ing modalities, QUS techniques do not use ionizing radiation for imaging, and can provide quantitative measures 
that are independent of instrument specifications and scan-session parameters for objective tissue characteriza-
tion. Also QUS methods do not require injection of any exogenous contrast agents since they rely on the physical 
and acoustic properties of tissues as source of imaging contrast.
In summary, the rapid characterization of breast lesions is an important component of breast cancer diagno-
sis that can keep more therapeutic options available for patients and improve survival and quality of life. In this 
context, non-invasive methods such as QUS texture-analysis framework proposed in this study can facilitate early 
characterization of breast lesions by providing complementary information on heterogeneous micro-structure of 
tissue. The results obtained in this study demonstrated a high potential for textural characteristics of QUS para-
metric maps to be applied in rapid diagnosis of cancerous breast tumours. This work provides a basis for future 
clinical studies in which the described framework is evaluated on larger cohorts of patients to assess its capabil-
ities further for robust, non-invasive and accurate characterization of benign versus malignant breast lesions.
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